Skye Bioscience (SKYE) Stock: Buy, Sell, or Hold?
SKYE - Skye Bioscience, Inc. Common Stock
$2.04
-0.04 (-1.92%)
▼
5d:
+14.61%
30d:
+271.65%
90d:
+155.16%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 20, 2026
0d
Get Alerted When SKYE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SKYE shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SKYE shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: SKYE is currently trading at $2.04, which is considered extended relative to its 30-day fair value range of $0.47 to $1.98.
Technical Outlook: Technically, SKYE is in a uptrend. Immediate support is located at $1.64, while resistance sits at $2.25.
Market Sentiment: SKYE scores 9/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $68.00 (+3233.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SKYE is in a uptrend. Immediate support is located at $1.64, while resistance sits at $2.25.
Market Sentiment: SKYE scores 9/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $68.00 (+3233.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.47 -
$1.98
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (9/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 3233.3% below Wall St target ($68.00)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.47 -
$1.98
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.64
Resistance Level
$2.25
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.28
Wall Street Target
$68.00
(+3233.3%)
Share & Embed Analysis
Last updated: September 13, 2026 7:19 PM ET
Data refreshes hourly during market hours. Next update: 8:19 PM
Data refreshes hourly during market hours. Next update: 8:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SKYE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 45 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 55 HOLD |
|
JSPR
Jasper Therapeutics Inc |
STRONG BUY
11 analysts |
$7 | 62 BUY |
|
RLAY
Relay Therapeutics Inc |
STRONG BUY
13 analysts |
$27 | 64 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 44 HOLD |
